According to the Form 4 filed as part of the sale, Thiel still holds roughly 180 million shares of Palantir -- leaving him with nearly 7% ownership of the entire company after the sale.

Palantir Technologies Inc. is a public American company that specializes in software platforms for big data analytics. Headquartered in Denver, Colorado, it was founded by Peter Thiel, Nathan Gettings, Joe Lonsdale, Stephen Cohen, and Alex Karp in 2003.

Thiel's second-largest stock holding is AbCellera Biologics Inc (ABCL), a biotechnology company focused on antibody discovery and development. As of December 15, 2020, Thiel owned 14,360,427 shares of AbCellera, valued at $55 million and representing a 2.58% weighting in his stock portfolio.

Palantir Gotham is a modern solution for efficient and responsible target management. Users can centrally manage intelligence gathering and target identification, leveraging a shared and access-controlled common intelligence, operating, and targeting picture to visualize order of battle.